Editas Medicine to Participate in Upcoming Investor Conferences
Editas Medicine (NASDAQ: EDIT), a gene editing company, has announced its participation in three major healthcare investor conferences in September 2025. The company will attend the Wells Fargo Healthcare Conference on September 3 in Boston, the Cantor Global Healthcare Conference on September 4 in New York featuring a fireside chat at 11:30 a.m. ET, and the Baird Global Healthcare Conference on September 9 in New York.
Live webcasts of available presentations can be accessed through the Investors section of Editas Medicine's website, with replays available for approximately 30 days after each event.
[]Editas Medicine (NASDAQ: EDIT), azienda di editing genetico, ha comunicato la sua partecipazione a tre importanti conferenze per investitori del settore sanitario a settembre 2025. La società sarà presente al Wells Fargo Healthcare Conference il 3 settembre a Boston, al Cantor Global Healthcare Conference il 4 settembre a New York con un’intervista informale (“fireside chat”) alle 11:30 ET, e al Baird Global Healthcare Conference il 9 settembre a New York.
I webcast in diretta delle presentazioni disponibili potranno essere seguiti nella sezione Investors del sito di Editas Medicine; le registrazioni resteranno accessibili per circa 30 giorni dopo ogni evento.
Editas Medicine (NASDAQ: EDIT), una compañía de edición genética, ha anunciado su participación en tres importantes conferencias para inversores del sector sanitario en septiembre de 2025. La empresa acudirá al Wells Fargo Healthcare Conference el 3 de septiembre en Boston, al Cantor Global Healthcare Conference el 4 de septiembre en Nueva York con una charla informal (“fireside chat”) a las 11:30 a. m. ET, y al Baird Global Healthcare Conference el 9 de septiembre en Nueva York.
Los webcasts en directo de las presentaciones disponibles se podrán ver en la sección Investors del sitio web de Editas Medicine; las repeticiones estarán disponibles durante aproximadamente 30 días tras cada evento.
Editas Medicine (NASDAQ: EDIT), 유전자 편집 회사는 2025년 9월에 열리는 주요 의료 투자자 콘퍼런스 세 곳에 참가한다고 발표했습니다. 회사는 9월 3일 보스턴에서 열리는 Wells Fargo Healthcare Conference, 9월 4일 뉴욕에서 개최되는 Cantor Global Healthcare Conference에 참가하며 이 자리에서 동부시간 기준 오전 11시 30분에 파이어사이드 채팅(fireside chat)을 진행하고, 9월 9일 뉴욕의 Baird Global Healthcare Conference에도 참석합니다.
이용 가능한 프레젠테이션은 Editas Medicine 웹사이트의 Investors 섹션에서 라이브 웹캐스트로 시청할 수 있으며, 각 행사 후 약 30일 동안 다시보기로 제공됩니다.
Editas Medicine (NASDAQ: EDIT), une société d'édition génétique, a annoncé sa participation à trois grandes conférences pour investisseurs du secteur de la santé en septembre 2025. La société assistera au Wells Fargo Healthcare Conference le 3 septembre à Boston, au Cantor Global Healthcare Conference le 4 septembre à New York avec une discussion informelle (« fireside chat ») à 11h30 ET, et au Baird Global Healthcare Conference le 9 septembre à New York.
Les webcasts en direct des présentations disponibles seront accessibles via la section Investors du site d'Editas Medicine ; les replays seront disponibles pendant environ 30 jours après chaque événement.
Editas Medicine (NASDAQ: EDIT), ein Unternehmen für Geneditierung, hat seine Teilnahme an drei wichtigen Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Wells Fargo Healthcare Conference am 3. September in Boston teilnehmen, am Cantor Global Healthcare Conference am 4. September in New York mit einem Fireside-Chat um 11:30 Uhr ET auftreten und am Baird Global Healthcare Conference am 9. September in New York vertreten sein.
Live-Webcasts der verfügbaren Präsentationen sind im Bereich Investors auf der Website von Editas Medicine abrufbar; Wiederholungen sind jeweils für etwa 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in September:
- Wells Fargo Healthcare Conference
Format: One-on-one Meetings
Date: Wednesday, September 3
Location: Boston, MA
- Cantor Global Healthcare Conference
Format: Fireside Chat with Webcast and One-on-one Meetings
Date: Thursday, September 4
Time: 11:30 a.m. ET
Location: New York, NY
- Baird Global Healthcare Conference.
Format: Presentation and One-on-one Meetings
Date: Tuesday, September 9
Location: New York, NY
To access the live webcasts (where available) of Editas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.
About Editas Medicine
As a pioneering gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of transformative in vivo medicines for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize durable, precision in vivo gene editing medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute’s Cas12a patent estate and Broad Institute and Harvard University’s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Investor and Media Contacts: ir@editasmed.com media@editasmed.com
FAQ
When is Editas Medicine (EDIT) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Editas Medicine's (EDIT) conference presentations?
Which investor conferences will Editas Medicine (EDIT) attend in September 2025?
How long will Editas Medicine's (EDIT) conference presentation replays be available?
